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Recent founder mutations may play important roles in complex diseases and Mendelian disorders. Detecting shared
haplotypes that are identical by descent (IBD) could facilitate discovery of these mutations. Several programs
address this, but are usually limited to detecting pair-wise shared haplotypes and not providing a comparison of
cases and controls. We present a novel algorithm and software package, HaploShare, which detects extended
haplotypes that are shared by multiple individuals, and allows comparisons between cases and controls. Testing on
simulated and real cases demonstrated significant improvements in detection power and reduction of false positive
rate by HaploShare relative to other programs.Background
Although genome-wide association studies (GWAS) have
revealed numerous common susceptibility variants for
complex diseases [1,2], only a small fraction of disease
heritability can be explained [3,4]. Rare variants may be a
major source of genetic variations that predisposes indi-
viduals to disease [5-7], but their detection is often diffi-
cult. The low penetrance or effect size of rare variants, as
well as genetic heterogeneity, often means that they are
unlikely to be detected by classical linkage analysis, and
their low allele frequency significantly reduces the power
of association studies. Next generation sequencing tech-
nologies can detect rare variants [7], but firmly establish-
ing a link between them and an underlying disease is
difficult without robust statistical methods or functional
characterization [6,8].
While common variants are mostly shared across eth-
nic groups, rare variants are more likely to be recent in
history and population-specific. Some are recent founder
mutations, shared by a number of individuals whose re-
lationship may not be socially known. Recent founder
mutations playing a role in a disease should aggregate
more in cases than in controls and the haplotypes in* Correspondence: yangwl@hku.hk
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unless otherwise stated.which they reside should have been affected by only a lim-
ited number of recombination events, unlike haplotypes
in the general population. Making use of this distinction
may aid the detection of recent haplotypes among cases
and facilitate detection of founder mutations.
Many efforts have been made in recent years to identify
haplotypes shared IBD, with the aim of locating disease
genes [9-13]. A drawback of most of these algorithms is
that haplotype frequency was not taken into consider-
ation, which limits the detection power and thus, they are
only suitable to detect very long haplotypes shared IBD.
PLINK [14] and GERMLINE [15] are two programs that
are quite efficient in processing genome-wide SNP geno-
typing data, but PLINK has low power in detecting shorter
haplotypes IBD and GERMLINE has a high false positive
rate when trying to detect smaller shared regions [16].
BEAGLE-IBD simultaneously models linkage disequi-
librium (LD) between markers and IBD sharing using a
Hidden Markov Model, and showed significant improve-
ments in power over earlier programs [16]. However, its
computational burden prevents it from being applied to
large samples. Having to determine the prior IBD prob-
ability is also a potential issue in trying to balance detec-
tion power and false positive rate, since suitable priors
may vary among populations that differ in history and
consanguinity. BEAGLE fastIBD can be applied to large
samples while achieving power close to that of BEAGLE
IBD [17]. The program still only works on sharing at a
pair-wise level and does not provide a comparison betweenis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ciated with diseases.
Several more recent algorithms begin to expand infer-
ence of haplotype-sharing IBD from pair-wise sharing to
that among multiple individuals. DASH and EMI builds
upon pair-wise haplotype sharing to infer groups of indi-
viduals who are likely to share a single haplotype [18]. A
Markov Chain Monte Carlo (MCMC) probabilistic
model applied to unphased SNP data to simultaneously
infer haplotype sharing IBD among multiple individuals
(MCMC_IBDfinder) was also reported [19]. Based on an
embedded log-likelihood ratio and using a model that
accounts for LD, Parente2 explicitly models haplotype
frequencies and enables large-scale IBD detection [20].
IBD-Groupon makes use of pair-wise IBD relationships
detected by other software to infer group-wise haplotype
sharing, overcoming the drawbacks of some of the avail-
able tools [21]. DASH was used to test diverse GWAS
data and showed a significant power increase upon sin-
gle SNP association, but the power of the algorithm in
detecting haplotypes shared IBD by a very small number
of cases and/or short haplotypes is unclear. In addition,
the power of DASH and IBD-Groupon is dependent on
the power of detecting pair-wise haplotype sharing.
MCMC_IBDfinder has good power in detecting short
shared haplotypes, but it does not provide a comprehen-
sive evaluation process using controls, and is not efficient
enough to be applied to GWAS data. The detection power
and speed of EMI and IBD-Groupon very much rely on
the performance of BEAGLE.
Thus, despite significant progress in developing algo-
rithms to infer haplotypes shared IBD among cases,
many problems remain and a comprehensive program
applicable to case–control data and with adequate power
and efficiency is still lacking. Here we introduce a new
algorithm, implemented in HaploShare, designed to have
high power when detecting extended haplotypes shared
by multiple individuals and the efficiency to be applied
to large data sets. Most importantly, it extends an evalu-
ation process using controls to derive an empirical null
distribution for the population of interest, to help iden-
tify sharing in cases that may harbor disease-associated
rare variants.
Results
Factors affecting detection sensitivity
Different scenarios of population-based association stud-
ies were simulated by dividing the Hong Kong ethnic
Chinese samples randomly into ‘case’ and ‘control’
groups of 1,000 each, and creating recent founder haplo-
types of different ages (generations) that were shared by
different numbers of ‘cases’ but not by ‘controls’. In all
the simulations, a positive detection was defined as the
simulated recent founder haplotype reaching a significanceof 0.05 (which refers to quasi P value, defined in Methods,
step 7), based on the empirical null distributions of log-
likelihood ratio of sharing by IBD vs. random chance that
was derived from haplotype sharing from controls (step 6
in Figure 1).
These results indicate that both the age of the founder
mutation and the number of cases sharing the same
founder haplotype affect detection of the haplotypes.
When a threshold of 1 cM was used to select pair-wise
haplotype-sharing (step 3 of the algorithm), and 10 of
1,000 individuals carried the founder mutation, Haplo-
Share had an adjusted detection power of almost 1 for
mutations 10 generations old. This dropped to 0.23 for
50-generation-old mutations (Figure 2A, right panel).
For a 10 generation founder mutation the detection sen-
sitivity was 0.99 if 10 cases shared the haplotype, but
0.76 if only four of the 1,000 ‘cases’ did (Figure 2B). The
overall size of the case sample pool considered, however,
had little effect on adjusted detection power. For five
cases sharing an ancestral haplotype of 10 generations in
a pool of 500, 800, or 1,000 total individuals, detection
sensitivity remained almost unchanged (Figure 2C),
reflecting the robustness of the algorithm against hetero-
geneity. This is an important characteristic of the algorithm
as its purpose is to detect very rare variants associated
with the underlying disease.
Power comparison between HaploShare and other
programs
As BEAGLE IBD, PLINK, and GERMLINE only detect
pair-wise haplotype sharing without controls, detection
sensitivity was compared on haplotypes shared pair-wise,
ignoring control data for this purpose. Five out of 100
individuals were assigned founder haplotypes of 10 to 50
generations old for the simulation. These five individuals
carry five founder haplotypes, or 500 haplotypes in total
over 100 iterations of the simulation. Haplotypes de-
tected as shared by multiple individuals by HaploShare
were measured by the number of individuals detected as
sharing a founder haplotype (if four shared an extended
haplotype, then four are considered found and one is
considered missed for the simulation). In addition, steps
1 to 3 only of the HaploShare algorithm (Figure 1) were
also examined without performing the multiple sharing
evaluation for comparison on detection of pair-wise
sharing. Only 100 individuals were used due to the com-
putational demand of BEAGLE IBD. For comparison
with DASH, as suggested by the program, we provided
pair-wise sharing results from GERMLINE as input in
calculation of detection of shared haplotypes. For com-
parison with IBD-Groupon, the pair-wise sharing results
from BEAGLE fastIBD were provided as input. For all
the programs, detection was defined as the simulated
founder haplotype surpassing a preset threshold for
Figure 1 Flow chart of the steps taken by HaploShare.
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parameters used for these programs were described in
the Additional file. All the adjusted power was shown
in Table 1. We also calculated the 95% confidence in-
tervals of the adjusted power by bootstrap resampling
in R (Additional file 1: Table S2).
It is worth noting that the method for calculation of
detection power described above was not directly count-
ing iterations, but counting the fraction of individuals
being detected in each iteration. Meanwhile, the false
positive rate for each program was not strictly con-
trolled in the power comparison. Therefore, we used the
term ‘adjusted power’ instead of ‘power’ in the description
of the results. We also used an alternative evaluationmethod, in which the power was calculated only based on
the iterations when all the individuals who carry the simu-
lated founder haplotypes were being detected, while miss-
ing any individual with the simulated founder haplotype
was defined as a negative detection. The result of this al-
ternative method was presented in Additional file 1: Table
S1. It can be seen that very low detection power was ob-
served for short haplotypes for all the programs evaluated
using this method.
When detecting pair-wise sharing only, HaploShare
outperformed other programs for haplotypes of 20 to 30
generations old and this advantage was even greater if
multiple sharing was considered (Table 1 and Additional
file 1: Table S2). The length cutoff in selecting haplotypes
Figure 2 Detection of simulated founder haplotypes. The dashed curves are the null distributions of log likelihood ratio derived from controls
(step 6, Figure 1) and the solid curves are those of the simulated founder haplotypes. The dashed line perpendicular to x-axis represents the
cutoff based on the separation of 95/5% of area under curve of the null distribution. (A) Effect of the age of the simulated founder haplotypes on
detection sensitivity. The left panel shows the null distribution of the log likelihood ratio from controls (dashed curves) and the simulated founder
haplotypes of 10, 20, and 30 generations, respectively (solid curves). The bar chart on the right is the detailed adjusted detection power for
founder haplotypes of different ages (generations). The simulations were based on 10 individuals sharing an ancestral haplotype among a total of
1,000 individuals. Data on 1,000 individuals were used as controls. (B) Effect of the number of individuals sharing a simulated founder haplotype
on detection sensitivity. The left three figures show the separation of log likelihood ratios for the recent ancestral haplotypes from that of the
controls when four, seven, and 10 individuals among 1,000 cases share an ancestral haplotype IBD of 10 generations, respectively. They were also
evaluated against 1,000 controls. The bar chart on the right shows the detailed detection sensitivity difference by the number of individuals
sharing a common ancestral haplotype. (C) Effect of the total pool of cases considered on detection sensitivity. The three figures on the left show
results when five individuals sharing a common recent ancestral haplotype of 10 generations in age, and are evaluated in a pool of 500, 800, and
1,000 cases, respectively. In each case, 1,000 individuals were used as controls in the evaluation process. The bar chart on the right shows the
detection sensitivity in the three different scenarios.
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HaploShare. At a cutoff of 0.5 cM instead of 1.0 cM, ad-
justed detection power increased, especially for founder
haplotypes of older age (Table 1 and Additional file 1:
Table S3). HaploShare was more powerful than other pro-
grams even when only pair-wise evaluation was per-
formed. This indicates that the improved power of
HaploShare was not solely based on the multiple sharing
analysis scheme.
PLINK and DASH are programs that make use of case
control data. Identification of shared haplotypes that
reach statistical significance based on the controls byPLINK, DASH, and HaploShare was examined. Two,
five, or 10 out of 1,000 individuals were assigned founder
haplotypes of 10 to 50 generations of age. HaploShare
showed higher adjusted power in detecting shared ex-
tended haplotypes reaching significance (Table 2 and
Additional file 1: Table S4, S5) as well as simulated hap-
lotypes reaching detection threshold (Table 1). However,
these data also showed that a number of the simulated
founder haplotypes were detected but did not reach stat-
istical significance.
To address a potential issue that might arise from the
similarity in the simulation of the shared founder
Table 1 Comparison of adjusted power on detecting pair-wise haplotype-sharing IBD between HaploShare, BEAGLE,
GERMLINE, PLINK, DASH, and IBD-Groupon
Age of
simulated
regions
(generations)
Length
(cM)
HaploShare
(multiple)b
HaploShare
(pair-wise)c
BEAGLE
IBD
BEAGLE
fastIBD
PLINK GERMLINE DASH plus
GERMLINE
BEAGLE plus
IBD-Groupon
Thresholda 1 cM 0.5 cM 1 cM 0.5 cM N/A N/A 0.5 Mb 0.5 cM 0.5 cM N/A
50 1.14 45.1 47.8 30.2 38.7 36.6 30.8 0.0 41.9 36.4 29.2
40 1.28 51.9 54.6 35.9 46.9 41.4 40.8 0.0 44.7 40.3 39.3
30 1.53 94.8 95.1 66.6 81.4 49.2 48.8 19.1 49.2 47.7 49.2
20 2.35 97.7 97.8 80.0 90.1 73.2 73.9 39.2 61.1 62.3 73.7
10 4.18 100.0 100.0 94.6 96.9 97.1 96.2 65.6 70.1 72.6 96.5
All results shown here are detections of pair-wise sharing reaching threshold based on respective thresholds in respective programs, no comparison to controls
was involved.
aFor HaploShare, GERMLINE, DASH, and PLINK, it is the minimum genetic distance (or physical distance) of the haplotypes shared pair-wise to be selected for
further analysis; for BEAGLE, it is the prior IBD probability; for BEAGLE fastIBD, it is the fastIBD score, and for IBD-Groupon, it is also the fastIBD score.
bHaplotypes shared pair-wise surpassing a certain genetic distance (0.5 or 1 cM) are further analyzed for sharing by multiple individuals, which by itself increases
power of detecting more individuals sharing an extended haplotype (Step 4, Figure 1).
cAnalysis stops at only detecting haplotypes shared pair-wise without merging pair-wise sharing into sharing by multiple individuals (stops at Step 3, Figure 1).
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by HaploShare, an alternative set of founder haplotypes
was also generated (described in Methods). With
shared haplotypes by siblings phased by BEAGLE serv-
ing as the shared recent founder haplotypes, Haplo-
Share achieved comparable adjusted power to when
using founder haplotypes generated by its own algo-
rithm (Additional file 1: Table S6), indicating that gen-
erating and detecting founder haplotypes both by
HaploShare did not cause inflation in adjusted power.
This alternative set of founder haplotypes were also
used to test other tools and the results were consistent
for founder haplotypes generated by different methods
(Additional file 1: Table S7). Similarly, we have done
testing and evaluation of HaploShare and other soft-
ware using WTCCC data, a widely used data sourceTable 2 Adjusted power and rank of the simulated founder h
BEAGLE fastIBD, and DASH
Software HaploShare
Threshold Pair-wise IBD >1.0 cM,
P <0.05
Pair-wise IBD >0.5 cM,
P <0.05
Total number of
haplotypes founda
5 found 32 found
Number of samples
sharing the simulated
haplotype
2 5 10 2 5 10
Age of simulated
founder haplotype
(generations)
10 1 (74) 1 (83) 1 (99) 4 (91) 3 (95) 3 (99
20 1 (60) 1 (78) 1 (86) 10 (73) 8 (85) 6 (90
30 2 (34) 2 (47) 1 (60) 20 (50) 19 (64) 15 (7
40 3 (19) 3 (26) 2 (39) 24 (39) 23 (47) 21 (5
50 5 (09) 4 (13) 3 (23) 27 (32) 27 (39) 27 (4
Shown are the rank and (detection power %) of the simulated haplotypes.
aTotal extended haplotypes found are an average of all the extended haplotypes sh
power) includes one simulated founder haplotype shared by two, five, or 10 sample
haplotypes shared by 20 samples (2%) or fewer were analyzed. When 1 cM was use
haplotypes reaching significance on average, including the simulated founder haplo
ing significance. Any of the haplotypes found repeatedly in different simulations wefrom subjects of European ancestry. Comparable re-
sults were achieved (Additional file 1: Table S8), indi-
cating that the performance of the various programs is
not dependent on the data and is not population-
specific.
Evaluation of false positive detections
Extended haplotypes that were shared by a number of
case individuals but without intrinsic relationship with
the underlying disease may still reach significance and
were considered false positive detections for the sake of
testing the different tools, even though some of them
might be true IBD derived from a recent common
founder. Log likelihood ratios of sharing by IBD vs.
chance for extended haplotypes detected from control
samples (see Methods) follow a shifted Gamma distributionaplotypes among all the regions found by HaploShare,
BEAGLE fastIBD DASH + GERMLINE
fastIBD score <10−10 <10−12 15 found Pair-wise IBD >0.5 cM
139 found 89 found
2 2 2 5 10
) 32 (95) 11 (35) 50 (65) 46(75) 38 (82)
) 45 (69) 13 (21) 60 (53) 57 (65) 54 (71)
2) 88 (41) 14 (16) 68 (41) 65 (49) 64 (52)
3) 107 (34) 15 (12) 75 (35) 75 (39) 75 (45)
1) 125 (28) 15 (11) 76 (30) 80 (33) 80 (37)
ared reaching significance from 100 simulations, which usually (depending on
s in each simulation. The total sample size in each simulation is 1,000 and
d as the threshold for selecting haplotypes shared pair-wise, there were five
type. When 0.5 cM was used as the threshold, there were 32 haplotypes reach-
re only counted once.
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the largest likelihood ratios (the extreme values) derived
from iterations by repeated applications of this process
was obtained and it follows a Gumbel distribution. The
right tail to the P = 0.05 point of this distribution (dashed
curve, Additional file 1: Figure S2) was used to obtain a
cutoff for the log likelihood ratio of an extended haplo-
type. At a selection threshold for pair-wise sharing of
1 cM, on average 7.3 × 105 extended haplotypes shared by
two to 20 individuals among a pool of 1,000 people were
found and evaluated, and on average, nine surpassed the
quasi P value cutoff in 100 repeats. Comparing these
shared haplotypes in cases with those by controls showed
that on average 4.4 of them were likely to be shared by
both cases and controls without significant frequency dif-
ference between the two groups, and they were removed
from further consideration, leaving 4.6 false positives on
average. This gave an empirical false positive rate of
6.28 × 10−6 (Additional file 1: Table S9). The false discov-
ery rate (FDR) depends on the ratio of shared extended
haplotypes associated with the underlying disease and
those that are not, which is an unknown parameter. As-
suming 10,000 or 1,000 non-disease associated shared
haplotypes would be evaluated for each disease associated
haplotype with significant quasi P value, then FDR was
calculated as 0.059 or 0.006, respectively. Reducing the
threshold for selection of pair-wise sharing from 1 cM to
0.5 cM increased adjusted power but caused a slight in-
crease in the false positive rate and FDR (Additional file 1:
Table S9).
We also compared the adjusted power of HaploShare
with BEAGLE fastIBD + IBD-Groupon under the same
level of false positive rate. Parameters from HaploShare
and BEAGLE were adjusted so that the same number of
non-simulated findings were detected, which made the
false positive rate identical between the two methods.
Summarized results showed that when controlling the false
positive rate, HaploShare still demonstrated superb power
against BEAGLE fastIBD + IBD-Groupon (Additional file 1:
Table S10).
An important concern is how many such shared ex-
tended haplotypes will be found and, what would be the
rank of the recent founder haplotypes associated with
diseases among all such regions found. Under the condi-
tions above, the ranks of simulated founder haplotypes
shared by two, five, or 10 samples (0.02%, 0.05%, and 1%
of the cases) among all haplotypes reaching the thresholdTable 3 Comparison of computing time between HaploShare,
Input data HaploShare BEAGLE (IBD) BEA
(100 cases, 500 controls) (100 cases) (10
Phased genotype 21 h 115 h 4 m
Unphased genotype 29 h 116 h 38 mwere in the range of 1 to 5 on average from the 100 simu-
lations (Table 2 and Additional file 1: Table S11), depend-
ing on the age of the haplotype and the number of the
individuals who shared it. This was significantly better
than BEAGLE fastIBD and DASH tested on the same
dataset, which either detected too many regions and
ranked poorly the simulated founder haplotypes (BEAGLE
fastIBD using fastIBD score of 1 × 10−10 and DASH using
pair-wise results from GERMLINE and pair-wise IBD
>0.5 cM), or had unacceptable power if 1 × 10−12 was used
as the fastIBD score (Table 2).
For HaploShare, 1 cM as selection threshold for ex-
tended haplotypes shared pair-wise gave a good balance of
adjusted power and false positive detection. At a threshold
of 0.5 cM, many more extended haplotypes reached sig-
nificance (32 vs. 5), and the simulated founder haplotypes
had much lower ranking among all the significant haplo-
types detected. A significant gain in adjusted power was
observed using 0.5 cM as the threshold (Table 2) if small
numbers of individuals (for example, two or five of 1,000)
shared a founder haplotype, but little if more did (for ex-
ample, 10).
Computing efficiency
To investigate computing efficiency, 100 samples were
selected as cases for both HaploShare and other pro-
grams. An additional 500 samples were provided for
HaploShare as controls. GERMLINE, PLINK, and BEA-
GLE fastIBD took 2, 3, and 4 min, respectively, and
DASH took 3 min processing results from GERMLINE,
to process the 100 samples while BEAGLE IBD took
nearly 5 days. HaploShare took 29 h to finish dealing
with 100 cases and repeatedly (1,000 times) drawing 100
samples from controls to generate the empirical null dis-
tribution of extended haplotype sharing. The major
computationally expensive step for HaploShare was to
combine pair-wise shared haplotypes into sharing by
multiple individuals, a process not adopted by other pro-
grams. Detection of pair-wise sharing by HaploShare
took 5 min for 100 cases, comparable to the other faster
programs (Table 3).
There is a significant increase in computing time if the
threshold for selecting pair-wise shared haplotypes is re-
duced. A cutoff of 0.5 cM takes three times as long to
compute as a cutoff of 1 cM. On a larger dataset with
500 cases and 1,000 controls, nearly 88 h were required
to finish the analysis. The time complexity is approximatelyBEAGLE, GERMLINE PLINK, and DASH
GLE (fastIBD) GERMLINE DASH plus GERMLINE PLINK
0 cases) (100 cases) (100 cases) (100 cases)
in 2 min 5 min N/a
in N/a N/a 3 min
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test was run on a computer with Intel® Core™2 Quad Pro-
cessor Q9650 and 8 GB of RAM.
Detection of a known recent founder haplotype (real
data)
A R114H mutation in the Ret proto-oncogene (RET) is
known to be associated with Hirschsprung’s disease and
shared by a small number of Chinese cases [22]. This
mutation was not found in any of the Chinese controls,
or in Caucasian cases or controls. An ancestral 250.2 kb
haplotype on which the mutation resided was found to
be shared by all the cases who carried the R114H RET
mutation but none of the non-carriers, indicating that
this mutation was probably derived from a recent
founder [22].
Data on 173 Hirschsprung’s disease cases and 436 con-
trols, all of whom Chinese ethnicity and genotyped by
an Affymetrix 500K chip, were analyzed. Based on theFigure 3 Illustration of an extended haplotype shared by multiple ind
haplotype in a region composed of 23 SNPs with six LD haplotype blocks.
individuals. The shared haplotype in each LD block (middle panel) and the
5, three samples share both haplotypes. In this case, the haplotype with aoriginal study, 14 of the 173 cases carry the R114H RET
mutation. Evaluation by HaploShare showed that the ex-
tended haplotype on which the R114H RET mutation re-
sided had a significant quasi P value of 0.004. Several
other extended shared haplotypes reached empirical sig-
nificance (31 regions with quasi P <0.05 and nine re-
gions with quasi P <0.01), which could be additional
recent founder haplotypes still to be confirmed, or false
positive results caused by population stratification or
random chance. The haplotype that the R114H RET mu-
tation resided on ranked fourth among all the significant
haplotypes.
For the RET locus, a shared haplotype of about 7 Mb,
much bigger than the reported haplotype in the original
study, was detected although the region has a genetic
distance of about 1 cM only (Figure 3). Nine of the 14
cases carrying the mutation were identified directly
using a threshold of 0.5 cM for selecting pair-wise
shared haplotypes. Five additional cases were identifiedividuals. In this example, four individuals share an extended
Two blocks form the core haplotype that is shared by all four
ir frequencies (lower panel) are displayed below each block. For block
higher frequency is used during the evaluation process.
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0.25 cM, a built-in process of HaploShare for regions
with confirmed sharing of extended haplotypes. The
core haplotype region shared by all 14 cases spanned
about 220 kb, consistent with the original report [22].
Discussion
Next-generation sequencing technology greatly acceler-
ated the pace of novel mutation detections. However,
firmly establishing a link between detected variants and
an underlying disease is still difficult, largely due to the
low allele frequencies of the variants and the limited
number of individuals that can be sequenced. Detection
of extended haplotypes that are shared potentially IBD
among cases can help evaluate the rare variants found.
Conversely, the individuals and regions suggested by
such analyses can serve as candidates for next-
generation sequencing, focusing resources on a limited
number of individuals and/or regions that share a poten-
tial founder haplotype.
The HaploShare algorithm presented here facilitates
the detection of haplotypes potentially shared IBD
among multiple individuals, rather than only pairs, from
a case group based on equivalent analyses in a control
group. Haplotypes shared among small numbers of indi-
viduals (<2% as default cutoff ) are evaluated by log like-
lihood ratios of shared as IBD vs. shared by chance. By
comparing these ratios to a distribution of maximal
values from those equivalently analyzed in a control
group, statistically significant extended haplotype sharing
in cases can be identified with good power and reason-
able computational speed.
These features of HaploShare lead it to outperform
existing programs, showing greater adjusted power and
reduced false positives, while maintaining tractable com-
putational performance. By recording all possible haplo-
type pairs that can explain block-wise genotypes and all
possible transition between blocks, HaploShare can
overcome phase uncertainty that may have affected the
power of algorithms based on Hidden Markov Model,
which may account for most of its improvement in sen-
sitivity. HaploShare is more computationally intensive
than PLINK, GERMLINE, DASH, and BEAGLE fastIBD,
but delivers multiple shared haplotypes, rather than only
pair-wise sharing. Its computational performance is
much better than BEAGLE-IBD. Most importantly, dir-
ect comparison to the best sharing in controls help iden-
tify sharing that is likely associated with an underlying
disease.
HaploShare requires the control sample size to be lar-
ger than that of the cases. If this is not practical, Haplo-
Share can generate virtual samples according to LD
between blocks, SNP allele frequencies and block-wise
haplotype frequencies of existing samples or those fromHapMap or other studies. Many of the measures used to
generate empirical null distributions of shared haplo-
types reflected the compromises made due to lack of
huge number of controls in practice. An alternative ap-
proach is to treat cases that do not carry the haplotype
under evaluation as controls. This not only increases the
availability of control samples, but also provides an add-
itional measure that can reduce the false positive rate if
there is a population substructure mismatch between
cases and controls. Although homogeneous populations
are not essential for HaploShare, good matching of cases
and controls is desirable. This was highlighted in the
WTCCC Bipolar disorder dataset where greater case-
case IBD than control-control IBD was found, probably
due to different geographical origins between the cases
and controls [16].
Even in an outbred population, various cryptic rela-
tionships may exist. This may complicate the evaluation
of extended haplotype sharing and presents a major
source of false positive detections. HaploShare adopted a
non-region-specific approach to evaluate sharing of ex-
tended haplotypes genome-wide, based on the likelihood
ratios of sharing IBD vs. by chance to reduce false posi-
tive detections. To supplement this approach, an add-
itional step of region-specific comparison between cases
and controls was used to compare the detected regions
between cases and controls, to distinguish those specific
to a case group from the ones existing at the similar
level in the general population. This approach signifi-
cantly reduced false positive detection with little effect
on power based on simulation results (Additional file 1:
Table S5).
Increases in SNP coverage over that of the Illumina
Beadchip 610-Quad used in the examples here, such as
by making use of rare variants identified by either the
1000 Genome Project or other whole genome or exome
sequencing efforts (like the exon-chip) will likely in-
crease the power of detection. Thus, identification of
shared ancestral haplotypes of much older age or shared
by fewer individuals than demonstrated here should be
possible. With modest modification, HaploShare can be
made applicable to detection of potential haplotype-
sharing IBD on the same locus but on different alleles by
different pairs, to identify disease loci where allelic het-
erogeneity may exist. If parallel computing is imple-
mented, HaploShare is capable of working on thousands
of samples within days. HaploShare extends our ability
to evaluate extended haplotypes shared among cases that
are associated with diseases with a computationally prac-
tical procedure.
Conclusion
We have developed a novel algorithm and software
implementing it, HaploShare, for detecting shared
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by control data from the same population. HaploShare
tackles the issue of phase uncertainty by utilizing popula-
tion haplotype information and considering any combina-
tions of haplotypes that can explain genotypes in a region.
It is efficient enough to apply to large scale GWAS data.
Comparison of HaploShare and other methods on both
simulated and real data demonstrated its improved power
and reduced false positive rate.
Materials and methods
A flow chart of the seven-step processes that Haplo-
Share uses in detecting and evaluating haplotype-sharing
IBD is shown in Figure 1.
Step 1. Construction of a catalog of population
haplotypes
The entire genome of each control subject is divided
into regions of LD blocks and recombination hotspots
based on LD between SNPs in healthy controls, using a
modification of an earlier method [23]. A pair of SNPs is
considered to have strong or weak LD if the one-sided
upper 95% confidence bound of D’ is >0.98 or <0.90.
Pairs between these values are not considered. If (‘strong
LD’ pairs) / (‘strong LD’ pairs + ‘weak LD’ pairs) >0.95 in
a region, it is considered an LD block. Otherwise it is
treated as a recombination hotspot and these SNPs will
be considered individually. Evaluation of LD blocks and
hotspots starts from the most 5′ SNP in a chromosome.
Once the first pair of adjacent SNPs with strong LD is
identified, downstream SNPs are added to the block by
evaluating the LD of each addition with all SNPs in the
region, until the definition of an LD block is no longer
met or two adjacent SNPs are separated by >50 kb.
PHASE software [24,25] is then used to generate a cata-
log of haplotypes for each predefined LD block together
with their population frequencies.
If no control data are available, LD blocks and recom-
bination hotspots are defined from genetic distances be-
tween SNP markers obtained from HapMap. A genetic
distance smaller than 0.001 centiMorgans (cM) between
two adjacent SNPs within 10 kb extends an LD block.
The two methods usually generate similar results of LD
blocks and recombination hotspots (Additional file 1:
Figure S1). Phased data from the corresponding popula-
tion in HapMap will be used to generate a catalog of
haplotypes in this case.
Step 2. Phasing of genotypes in cases based on a
population haplotype catalog
Genotypes in cases in each LD block are phased into
haplotypes based on the population haplotype catalog.
Several scenarios may apply. (A) Only one pair of haplo-
types in the catalog can explain the genotypes in a block.(B) If more than one pair of haplotypes is consistent
with the genotypes in a block, all the possible pairs of
haplotypes will be recorded and used in later steps in
identifying haplotype sharing. (C) The genotype can only
be explained by a known haplotype together with a
haplotype that does not exist in the catalog. A low popu-
lation frequency, which is estimated as
hu < 1−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:952m
p
is assumed for the undetected haplotype. Here m is the
sample size of the controls used to generate the haplo-
type catalog and a 95% probability of a haplotype being
absent in the controls is assumed. (D) The genotypes are
not consistent with any of the known haplotypes in the
catalog. In this case, genotyping errors are assumed and
the LD block will not be used for initial detection of
haplotype sharing. However, it will not prevent extension
of a shared haplotype that contains it.
Step 3. Detecting pair-wise haplotype-sharing in cases
After obtaining phasing results for all the cases, pairs of
individuals are scanned and compared for potential
haplotype sharing across each chromosome. Only haplo-
types shared in an LD block (not SNPs in recombination
hotspots) are used to initiate matching. The shared re-
gion is extended in both directions while supported by
haplotypes in LD blocks or SNPs in hotspots, allowing
for potential genotyping errors. Genotyping errors are
tolerated if 1% or fewer SNPs in an extended haplotype
do not comply with haplotype-sharing. No incompatibil-
ity is allowed in the first and the last 20 SNPs of an ex-
tended shared haplotype to avoid false extensions.
Extended haplotypes shared pair-wise longer than a pre-
set genetic distance (such as 0.5 or 1 cM as used in the
simulations shown in this study) are selected and evalu-
ated for sharing among multiple individuals.
Step 4. Detecting haplotype-sharing by multiple samples
Haplotypes shared by pairs are compared with each
other to identify those that share at least part of an ex-
tended haplotype. They are merged when different pairs
overlap at least partially over the shared region on the
same allele. An extended haplotype shared by multiple
individuals is defined as a haplotype that is shared by at
least two individuals at any given point and contains a
core haplotype that has to cover at least one LD block
and be shared by all the individuals. An example of this
is illustrated in Figure 4. The method may miss individ-
uals who share a portion of the extended haplotype but
did not meet the selection threshold for pair-wise shar-
ing with any other samples in this group. To include
these in further analysis, the remaining samples are
scanned for those that share the entire core haplotype
Figure 4 Detection of the haplotypes carrying the RET mutation. The RET mutation region spans 7 Mb in physical distance but only 1 cM in
genetic distance, which contains 17 LD blocks. All 14 cases share the core haplotype composed of blocks 8 to 11; and the rest of the region is
shared by at least two cases at any given point. The frequency of the shared haplotypes in different blocks varies from less than 1% to 60%
among the Hong Kong Chinese population.
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least half the threshold initially used (see step 3 above).
Step 5. Estimating the likelihood ratio of a haplotype
shared by IBD vs. sharing by chance
Most shared haplotypes from the general population are
short and common, although physical length can be a
poor indicator [26]. True recent founder haplotypes,
however, are expected to be longer and may contain
multiple block-wise haplotypes of low frequency in the
population. Here we introduce an estimate of the likeli-
hoods of sharing due to IBD or by chance and use the
logarithm of their ratio to evaluate haplotype sharing
events.
If sharing is due to random chance, then inheriting
haplotypes from different blocks should be independent
events, disregarding weak LD between blocks. Thus, its
likelihood can be estimated as the product of the likeli-
hoods of inheriting haplotypes in different LD blocks.
The probability of sharing haplotype i in LD block j by
random chance by kj individuals is designated as Pj,
which, based on the population frequency of the shared
haplotype and the number of individuals who share the
haplotype, can be estimated as:
Pj ¼ hjikj ⋅
2
1
 kj
2k
k
 
The population frequency of haplotype i in block j is
hji. Here k is the number of individuals who share theextended haplotype, and kj is the number of individuals
in k that share haplotype i in block j and kj ≦ k.
2k
k
 
stands for the number of possible combinations of k
chromosomes from a total of 2 k chromosomes, and
2
1
 kj
indicates that one of the two haplotypes is shared
by each of the kj individuals. The likelihood of sharing
the extended haplotype by random chance is:
L H0ð Þ ¼ sk
 
⋅
Ym
j¼1
Pj
where s is the total number of individuals considered
(for example, the sample size of cases), and m is the total
number of LD blocks within this extended shared haplo-
type. Thus L(Ho) represents the probability of k individ-
uals sharing an extended haplotype by random chance,
and the extended haplotype has m LD blocks with re-
spective haplotype frequencies of hji. Only block haplo-
types are considered for the likelihood estimation.
If the region is shared due to inheritance from a recent
common ancestor, the likelihood can be estimated as a
function of the estimated age, n, of the shared haplotype
(generations) based on the genetic length of the region
and k, the number of individuals who share the extended
haplotype:
L H1ð Þ ¼ 0:5n⋅k
So n × k represents the total number of meioses in
shaping the shared extended haplotype and 0.5 is the
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Since different individuals may share different lengths of
the extended haplotype, n is estimated by the average
genetic distance dg (cM) of the shared haplotype for each
of the k individuals:
E dg
  ¼ 100
n
An inherited haplotype of 2 cM on average indicates
that approximately 50 meioses may have occurred in the
surrounding region, suggesting sharing of a common an-
cestor about 50 generations ago. The logarithm of the
likelihood ratio of sharing by IBD and sharing by chance
is then estimated as:
log10
L H1ð Þ
L H0ð Þ
Step 6. Estimating empirical null distribution using
controls
The likelihood ratio may be inflated due to weak LD be-
tween haplotype blocks. Differences in coverage over the
genome, especially on rare genetic variants may intro-
duce inaccuracies. Thus a genome-wide correction is ne-
cessary to make the likelihood ratio comparable across
different regions. A Monte Carlo simulation process is
used to survey the distribution of shared haplotypes in
healthy controls.
If a region is shared by k individuals among a total of s
cases, then s samples are selected randomly from the
total pool of controls. For these individuals, haplotype-
sharing is detected and the likelihood ratios of sharing
by IBD and sharing by chance are calculated as de-
scribed above. In each simulation, the largest likelihood
ratio from all the extended haplotypes in the entire gen-
ome shared by k or fewer individuals is recorded. The
reason of using the largest likelihood ratio from each it-
eration to calculate the null distribution in a population
rather than using those from all the extended haplotypes
evaluated is a reflection of the difficulty of estimating
the null distribution of the likelihood ratio while taking
the multiple testing issue into consideration. Since it is
very difficult to model the effect on likelihood ratios by
the age of the extended haplotype and the number of in-
dividuals sharing it, this constraint ensures that the ex-
tended haplotypes in cases that are more recent in
history are detected. This process is repeated at least
1,000 times by selecting different set of samples from
controls by random. If the available samples in the con-
trols are smaller than 2 s, virtual samples are generated
according to the SNP allele and block haplotype fre-
quencies of the existing samples, as detailed below. Each
simulation round uses the entire control sample exceptfor the extended haplotypes already selected and recorded,
to avoid repeated selection of the same haplotypes among
simulations. This is an approach addressing the issue that
the control samples are often not large enough to allow
repeated simulation without selecting the same subset of
individuals between different rounds.
This generates a collection of extreme values of likeli-
hood ratios on haplotype-sharing from controls, which
follow a Gumbel distribution, with the goodness of fit al-
ways reaching 0.99 or higher under Anderson-Darling test
performed in Matlab (P >0.01, accept H0, which indicates
that the data fit the distribution). Therefore, this distribu-
tion is treated as the empirical genome-wide null distribu-
tion of the likelihood ratios for haplotype-sharing in the
population of interest (shown as dashed curves in Figure 2
and Additional file 1: Figure S2), from which the type I
error can be estimated and thresholds determined based
on the area under the curve on the right tail.
If control samples are not available or are smaller than
twice of that of the cases, HaploShare generates a virtual
control data set based on the haplotypes and their popula-
tion frequencies based on HapMap data or the provided
controls. Briefly, for genotypes in blocks, two haplotypes
are randomly selected with probability proportional to
their population frequency. For genotypes in recombin-
ation hotspots, SNP alleles are chosen by a Markov model
with the chance of being selected proportional to its weak
LD to its 5′ SNP, as described previously [26]. This pro-
cedure ensures that the block-wise haplotype frequencies
and LD for recombination hotspot SNPs remain similar to
those in the original HapMap samples or the limited con-
trols provided.
Step 7. Evaluating the significance of log likelihood ratios
P values are defined as the probability of exceeding the
observed statistic under the null hypothesis. As men-
tioned above, the null hypothesis generated in this
method (step 6) was not based on all the extended hap-
lotypes evaluated, but the best ones from the iterations.
Therefore, to avoid confusion, we used the term ‘quasi P
value’ instead of ‘P value’ in this method. The ‘quasi P
value’ is not directly reflecting the false positive rate of
the method, but only evaluating the significance of each
haplotype sharing. The distribution generated in step 6
was applied to find the ‘quasi P values’ of the haplotype
sharings identified among the cases. Additional file 1:
Table S10 demonstrated the way to calculate the false
positive rates from certain quasi P values.
Step 8. Removing the extended haplotypes shared by
both cases and controls without significant frequency
differences
In order to further reduce false positive findings, signifi-
cantly shared haplotypes in cases are then compared to
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both location and allele, and without significant differ-
ences in the number of individuals who share the haplo-
type. For each shared haplotypes found to be significant
in cases, HaploShare examines the samples in all the
controls that carry the same haplotype by the following
criteria: (1) there is a complete overlap on the core
haplotype between sharing in cases and controls; (2) the
samples in controls also share over 50% of the entire ex-
tended haplotype shared in cases; and (3) there is no
significant difference in the frequency of the shared
haplotype between cases and controls based on Chi
square test (P >0.05). The haplotypes shared in cases as
well as in controls so defined are considered to be with-
out evidence of association with the underlying disease
and are removed from the findings.
Generation of datasets to evaluate HaploShare and other
programs
A real dataset of Hong Kong Chinese samples genotyped
using Illumina 610-Quad Beadchips was used to evaluate
this methodology (>2,800 individuals; see Additional file
for details of the data). The data was first used to evalu-
ate the phasing method introduced in HaploShare. Ge-
notypes from one set of 1,000 individuals were used to
generate the block-wise population haplotype catalog
and another set of 1,000 individuals was randomly
chosen to test the phasing process. About 91% of the
markers were found to be located in LD blocks and the
rest in recombination hotspots. Ninety-seven percent of
the block-wise genotypes could be explained by a unique
pair of haplotypes; 2.7% were explained by more than
one pair of haplotypes and 0.2% of the block-wise geno-
types could only be explained by one known haplotype
and an unknown haplotype. Very rarely were block-wise
genotypes (<0.01%) not compatible with any known
haplotype in this dataset, although this will depend on
the size of the control sample used and the error rate of
the genotyping platform.
To generate recent founder haplotypes, the meiosis
process was simulated as described previously [27]. In
each simulation, one sample was selected as an ‘ancestor’
and several samples as the last generation ‘descendants’.
The genotypes of the selected samples within LD blocks
were phased according to the block-wise haplotype cata-
log introduced above (or by using genotypes from family
members phased by BEAGLE, see below). LD between
two adjacent SNPs in recombination hotspots or between
LD blocks was modeled as described above. Therefore, LD
both within and between blocks was taken into account in
the phasing process.
After phasing, a single ‘ancestor’ SNP was randomly
chosen as the ‘founder mutation’. In the simulated meiosis
process, the extended haplotype carrying the mutationwas shortened through each simulated recombination
event [27]. Once the range of the haplotype carrying the
‘founder mutation’ was determined, one of the alleles in
its location in each of the last generation ‘descendants’
was replaced with the mutation-carrying founder haplo-
type to generate genotypes carrying this ancestral haplo-
type. The ‘affected descendants’ created this way were
mixed with other randomly chosen individuals in the
‘case’ group for testing HaploShare and other programs.
Additional file 1: Figure S3 shows the correlation of the
genetic distance and age (generations) of the founder
haplotypes simulated in this study.
An alternative method of generating founder haplo-
types that is less similar to the algorithm used by Haplo-
Share was also used in this study. It used data from 192
sib-pairs genotyped using Illumina 610-Quad Beadchip.
Regions potentially shared IBD between siblings were
defined as any region of more than 10 cM in genetic dis-
tance and contains fewer than 0.1% of markers with
complete genotype mismatch (discordant homozygous
genotypes). For each sib pair, 960 such potential IBD re-
gions of various lengths (1, 2, 3, 4, and 5 cM in genetic
distance) were randomly selected. Phasing of the IBD re-
gions was performed using BEAGLE [16]. The haplo-
types that were shared IBD between siblings were then
used as ‘founder haplotypes’ in the simulation process
described above and the sensitivity of HaploShare in de-
tecting the founder haplotypes generated by the two dif-
ferent methods was compared.
The false positive rate and the rank of the simulated
founder haplotypes among all the significant extended
haplotypes shared in the entire genome were evaluated.
One thousand individuals were randomly selected from
the real dataset of Hong Kong Chinese samples as test-
ing data in each simulation. In 100 replications each,
two, five, or 10 of the 1000 individuals were inserted
with a simulated recent founder haplotype of 10to 50
generations in age. All shared extended haplotypes (sim-
ulated and un-simulated) identified by HaploShare at a
significance level of quasi P <0.05 were counted and
ranked by their quasi P values. The average number of
shared haplotypes identified and the rank of the simu-
lated founder haplotypes were used to evaluate false
positive detection. Due to its design constraints, BEA-
GLE fastIBD can only use simulated pair-wise sharing of
haplotypes derived from these simulations as a test for
false positives.
Data availability
The program and the data used for test the programs
are available from the following websites:
1. WTCCC data: http://www.wtccc.org.uk/
Ying et al. Genome Biology  (2015) 16:92 Page 13 of 142. Hapmap genetic distance map: http://hapmap.ncbi.
nlm.nih.gov/downloads/recombination/
3. Hapmap phasing genotype: http://hapmap.ncbi.nlm.
nih.gov/downloads/phasing/?N=D
4. HaploShare (windows) and testing data: http://paed.
hku.hk/genome/software.html or https://github.com/
jonsonfox/HaploShare
Additional file
Additional file 1: Figure S1. Number of SNPs and the length of the
haplotype blocks. Figure S2. Estimation of false positive rate. Figure S3.
Length of pair-wise sharing (cM, overlapped region only) of the simulated
IBD regions of different age. Quality control of the testing data. The
parameters used for GERMLINE, BEAGLE, DASH, and PLINK. Table S1.
Alternative comparison of adjusted power on detecting pair-wise
haplotype-sharing IBD between HaploShare, BEAGLE, GERMLINE, PLINK,
DASH, and IBD-Groupon using an alternative method. Table S2. Ninety-five
percent confidence intervals of the adjusted power in Table 1. Table S3.
Comparison of adjusted power on detection of pair-wise haplotype-sharing
IBD between HaploShare and others (sort by length). Table S4. Ninety-five
percent confidence intervals of the adjusted power in Table 2. Table S5.
Adjusted power of detection on shared extended haplotype significantly
associated with diseases. Table S6. Adjusted power comparison on founder
haplotypes generated by two different methods. Table S7. Adjusted power
and rank of the founder haplotypes derived from sibpairs among all the
regions found by HaploShare, BEAGLE fastIBD, IBD-Groupon, and DASH.
Table S8. Comparison of adjusted power on detecting haplotype-sharing
IBD between HaploShare, BEAGLE, GERMLINE, PLINK, DASH, and IBD-Groupon
on simulated data from WTCCC data. Table S9. False positive rate
and false discovery rate. Table S10. Power comparison with same
false positive rate. Table S11. Ninety-five percent confidence
intervals of the rank in Table 2. Table S12. A breakdown of time
consumed by different steps by HaploShare.
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